163 related articles for article (PubMed ID: 29251621)
61. Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation.
Rettinger E; Merker M; Salzmann-Manrique E; Kreyenberg H; Krenn T; Dürken M; Faber J; Huenecke S; Cappel C; Bremm M; Willasch A; Bakhtiar S; Jarisch A; Soerensen J; Klingebiel T; Bader P
Biol Blood Marrow Transplant; 2017 Jan; 23(1):87-95. PubMed ID: 27742575
[TBL] [Abstract][Full Text] [Related]
62. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M
Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776
[TBL] [Abstract][Full Text] [Related]
63. Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention.
Mo XD; Lv M; Huang XJ
Br J Haematol; 2017 Oct; 179(2):184-197. PubMed ID: 28542711
[TBL] [Abstract][Full Text] [Related]
64. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
65. Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation.
Zhao XS; Liu YR; Zhu HH; Xu LP; Liu DH; Liu KY; Huang XJ
Ann Hematol; 2012 Feb; 91(2):183-92. PubMed ID: 21710165
[TBL] [Abstract][Full Text] [Related]
66. [Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation].
Tang XW; Wu DP; Xia XM; Sun AN; Zhu ZL; Ruan CG
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):98-101. PubMed ID: 15059404
[TBL] [Abstract][Full Text] [Related]
67. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
[TBL] [Abstract][Full Text] [Related]
68. Chimerism analysis following hematopoietic stem cell transplantation.
Murphy KM
Methods Mol Biol; 2013; 999():137-49. PubMed ID: 23666695
[TBL] [Abstract][Full Text] [Related]
69. Monitoring of pediatric patients with malignant hematological diseases after allogeneic HSCT: Serbian experience.
Krstic AD; Stojkovic O; Guc-Scekic M; Jevtic D; Zecevic Z; Vujic DS
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e253-7. PubMed ID: 22543520
[TBL] [Abstract][Full Text] [Related]
70. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
71. Real-time biallelic polymorphism-polymerase chain reaction for chimerism monitoring of hematopoietic stem cell transplantation relapsed patients.
Chen DP; Tseng CP; Wang WT; Wang MC; Tsai SH; Sun CF
Clin Chim Acta; 2011 Mar; 412(7-8):625-30. PubMed ID: 21185273
[TBL] [Abstract][Full Text] [Related]
72. Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms.
Valero-Garcia J; González-Espinosa MDC; Barrios M; Carmona-Antoñanzas G; García-Planells J; Ruiz-Lafora C; Fuentes-Gálvez A; Jiménez-Velasco A
PLoS One; 2019; 14(2):e0212708. PubMed ID: 30794643
[TBL] [Abstract][Full Text] [Related]
73. [Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
Czekalska S; Sacha T; Piatkowska-Jakubas B; Zawada M; Florek I; Cwynar D; Skotnicki AB
Przegl Lek; 2010; 67(12):1282-91. PubMed ID: 21591354
[TBL] [Abstract][Full Text] [Related]
74. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
Uzunel M; Ringdén O
Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
[TBL] [Abstract][Full Text] [Related]
75. Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning.
Shimoni A; Nagler A
Acta Haematol; 2004; 112(1-2):93-104. PubMed ID: 15179009
[TBL] [Abstract][Full Text] [Related]
76. [Application of short-tandem-repeat amplification and fluorescent-multiplex PCR for chimerism analysis].
Li SX; Zhu HL; Guo B; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):749-53. PubMed ID: 21729564
[TBL] [Abstract][Full Text] [Related]
77. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
78. Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
Tsirigotis P; Byrne M; Schmid C; Baron F; Ciceri F; Esteve J; Gorin NC; Giebel S; Mohty M; Savani BN; Nagler A
Bone Marrow Transplant; 2016 Nov; 51(11):1431-1438. PubMed ID: 27295272
[TBL] [Abstract][Full Text] [Related]
79. Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants.
Ortega M; Escudero T; Caballín MR; Olivé T; Ortega JJ; Coll MD
Bone Marrow Transplant; 1999 Jul; 24(1):81-7. PubMed ID: 10435740
[TBL] [Abstract][Full Text] [Related]
80. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
